Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity - Concepedia

Concepedia

Publication | Open Access

Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity

DOI Full Paper Access

226

Citations

57

References

2019

Year

Jacqulyne Robichaux, Yasir Y. Elamin, R.S.K. Vijayan, Monique B. Nilsson, Lemei Hu, Junqin He, Fahao Zhang, Marlese A. Pisegna, Alissa Poteete, Huiying Sun,

Pan-cancer LandscapeOncologyMedicineClinically Active InhibitorCancer GenomicsT-dm1 ActivityCell BiologyCancer GeneticsSystems BiologyCancer BiologyRadiation OncologyTumor Biology

References

	Year	Citations

Page 1

Page 1